PyIgClassify2: Canonical Clusters of Antibody CDR Loop Conformations

PyIgClassify2: Classification of Antibody CDR Conformations

CDRs for query 3RI5

#CDRs = 8; #Clusters = 8.
Chain	Gene	PDB Species	Frame Germline	Frame %	CDR Germline	CDR %	CDR	Length	Cluster	Distance(°)	Sequence	Ramachandran
F	heavy	Mus.musculus	Mo_IGHV1-37*01	93.2	Mo_IGHV1-37*01	92.3	H1	13	H1-13-1	9	KASGYSFTGYTMN	BBBLBBAAABBBB
F	heavy	Mus.musculus	Mo_IGHV1-37*01	93.2	Mo_IGHV1-37*01	70.0	H2	10	H2-10-1	11	LINPYNGGTS	BBBAAALBBB
F	heavy	Mus.musculus	Mo_IGHV1-37*01	93.2	Mo_IGHV1-37*01	100.0	H3	15	H3-15-*	-1	ARDGDYyRYGRYFDY
F	heavy	Mus.musculus	Mo_IGHV1-37*01	93.2	Mo_IGHV1-37*01	100.0	H4	8	H4-8-1	8	VDKSSSTA	BBAAALBB
G	heavy	Mus.musculus	Mo_IGHV1-37*01	93.2	Mo_IGHV1-37*01	92.3	H1	13	H1-13-1	9	KASGYSFTGYTMN	BBBLBBAAABBBB
G	heavy	Mus.musculus	Mo_IGHV1-37*01	93.2	Mo_IGHV1-37*01	70.0	H2	10	H2-10-1	11	LINPYNGGTS	BBBAAALBBB
G	heavy	Mus.musculus	Mo_IGHV1-37*01	93.2	Mo_IGHV1-37*01	100.0	H3	15	H3-15-*	-1	ARDGDYyRYGRYFDY
G	heavy	Mus.musculus	Mo_IGHV1-37*01	93.2	Mo_IGHV1-37*01	100.0	H4	8	H4-8-1	8	VDKSSSTA	BBAAALBB
H	heavy	Mus.musculus	Mo_IGHV1-37*01	93.2	Mo_IGHV1-37*01	92.3	H1	13	H1-13-1	9	KASGYSFTGYTMN	BBBLBBAAABBBB
H	heavy	Mus.musculus	Mo_IGHV1-37*01	93.2	Mo_IGHV1-37*01	70.0	H2	10	H2-10-1	11	LINPYNGGTS	BBBAAALBBB
H	heavy	Mus.musculus	Mo_IGHV1-37*01	93.2	Mo_IGHV1-37*01	100.0	H3	15	H3-15-*	-1	ARDGDYyRYGRYFDY
H	heavy	Mus.musculus	Mo_IGHV1-37*01	93.2	Mo_IGHV1-37*01	100.0	H4	8	H4-8-1	8	VDKSSSTA	BBAAALBB
I	heavy	Mus.musculus	Mo_IGHV1-37*01	93.2	Mo_IGHV1-37*01	92.3	H1	13	H1-13-1	9	KASGYSFTGYTMN	BBBLBBAAABBBB
I	heavy	Mus.musculus	Mo_IGHV1-37*01	93.2	Mo_IGHV1-37*01	70.0	H2	10	H2-10-1	11	LINPYNGGTS	BBBAAALBBB
I	heavy	Mus.musculus	Mo_IGHV1-37*01	93.2	Mo_IGHV1-37*01	100.0	H3	15	H3-15-*	-1	ARDGDYyRYGRYFDY
I	heavy	Mus.musculus	Mo_IGHV1-37*01	93.2	Mo_IGHV1-37*01	100.0	H4	8	H4-8-1	8	VDKSSSTA	BBAAALBB
J	heavy	Mus.musculus	Mo_IGHV1-37*01	93.2	Mo_IGHV1-37*01	92.3	H1	13	H1-13-1	9	KASGYSFTGYTMN	BBBLBBAAABBBB
J	heavy	Mus.musculus	Mo_IGHV1-37*01	93.2	Mo_IGHV1-37*01	70.0	H2	10	H2-10-1	11	LINPYNGGTS	BBBAAALBBB
J	heavy	Mus.musculus	Mo_IGHV1-37*01	93.2	Mo_IGHV1-37*01	100.0	H3	15	H3-15-*	-1	ARDGDYyRYGRYFDY
J	heavy	Mus.musculus	Mo_IGHV1-37*01	93.2	Mo_IGHV1-37*01	100.0	H4	8	H4-8-1	8	VDKSSSTA	BBAAALBB
K	lambda	Mus.musculus	Mo_IGLV1*01	100.0	Mo_IGLV1*01	85.7	L1	14	L1-14-1	7	RSSTGAVTTiNFAN	BBAAEBBBAAALBB
K	lambda	Mus.musculus	Mo_IGLV1*01	100.0	Mo_IGLV1*01	87.5	L2	8	L2-8-4	22	GGINNRAP	EEAABBBB
K	lambda	Mus.musculus	Mo_IGLV1*01	100.0	Mo_IGLV1*01	87.5	L3	9	L3-9-4	8	ALWYSNHWV	BBBBEABBB
K	lambda	Mus.musculus	Mo_IGLV1*01	100.0	Mo_IGLV1*01	100.0	L4	6	L4-6-*	-1	LIGDKA	BBEABB
L	lambda	Mus.musculus	Mo_IGLV1*01	100.0	Mo_IGLV1*01	85.7	L1	14	L1-14-1	7	RSSTGAVTTiNFAN	BBAAEBBBAAALBB
L	lambda	Mus.musculus	Mo_IGLV1*01	100.0	Mo_IGLV1*01	87.5	L2	8	L2-8-4	22	GGINNRAP	EEAABBBB
L	lambda	Mus.musculus	Mo_IGLV1*01	100.0	Mo_IGLV1*01	87.5	L3	9	L3-9-4	8	ALWYSNHWV	BBBBEABBB
L	lambda	Mus.musculus	Mo_IGLV1*01	100.0	Mo_IGLV1*01	100.0	L4	6	L4-6-*	-1	LIGDKA	BBEABB
M	lambda	Mus.musculus	Mo_IGLV1*01	100.0	Mo_IGLV1*01	85.7	L1	14	L1-14-1	7	RSSTGAVTTiNFAN	BBAAEBBBAAALBB
M	lambda	Mus.musculus	Mo_IGLV1*01	100.0	Mo_IGLV1*01	87.5	L2	8	L2-8-4	22	GGINNRAP	EEAABBBB
M	lambda	Mus.musculus	Mo_IGLV1*01	100.0	Mo_IGLV1*01	87.5	L3	9	L3-9-4	8	ALWYSNHWV	BBBBEABBB
M	lambda	Mus.musculus	Mo_IGLV1*01	100.0	Mo_IGLV1*01	100.0	L4	6	L4-6-*	-1	LIGDKA	BBEABB
N	lambda	Mus.musculus	Mo_IGLV1*01	100.0	Mo_IGLV1*01	85.7	L1	14	L1-14-1	7	RSSTGAVTTiNFAN	BBAAEBBBAAALBB
N	lambda	Mus.musculus	Mo_IGLV1*01	100.0	Mo_IGLV1*01	87.5	L2	8	L2-8-4	22	GGINNRAP	EEAABBBB
N	lambda	Mus.musculus	Mo_IGLV1*01	100.0	Mo_IGLV1*01	87.5	L3	9	L3-9-4	8	ALWYSNHWV	BBBBEABBB
N	lambda	Mus.musculus	Mo_IGLV1*01	100.0	Mo_IGLV1*01	100.0	L4	6	L4-6-*	-1	LIGDKA	BBEABB
O	lambda	Mus.musculus	Mo_IGLV1*01	100.0	Mo_IGLV1*01	85.7	L1	14	L1-14-1	7	RSSTGAVTTiNFAN	BBAAEBBBAAALBB
O	lambda	Mus.musculus	Mo_IGLV1*01	100.0	Mo_IGLV1*01	87.5	L2	8	L2-8-4	22	GGINNRAP	EEAABBBB
O	lambda	Mus.musculus	Mo_IGLV1*01	100.0	Mo_IGLV1*01	87.5	L3	9	L3-9-4	8	ALWYSNHWV	BBBBEABBB
O	lambda	Mus.musculus	Mo_IGLV1*01	100.0	Mo_IGLV1*01	100.0	L4	6	L4-6-*	-1	LIGDKA	BBEABB

Site developed by the Antibody Team at the lab of Roland Dunbrack. Last updated on Oct. 13, 2022